docetaxel anhydrous has been researched along with Central Retinal Edema, Cystoid in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Etminan, M; Maberley, D; Mikelberg, F; Sodhi, M; Yeung, SN | 1 |
Dalvin, LA; Fortes, BH; Liou, H | 1 |
Antoun, J; Arej, N; Chelala, E; El Karak, F; Farhat, F; Haddad, FG; Kattan, J; Kourie, HR; Zaarour, K | 1 |
Enzsoly, A; Kammerer, K; Nemeth, J; Schneider, M | 1 |
Teitelbaum, BA; Tresley, DJ | 1 |
5 other study(ies) available for docetaxel anhydrous and Central Retinal Edema, Cystoid
Article | Year |
---|---|
Risk of Ocular Adverse Events With Taxane-Based Chemotherapy.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Bridged-Ring Compounds; Child; Docetaxel; Female; Humans; Lacrimal Apparatus Diseases; Macular Edema; Middle Aged; Optic Nerve Diseases; Paclitaxel; Retrospective Studies; Tamoxifen; Taxoids | 2022 |
Ophthalmic adverse effects of taxanes: The Mayo Clinic experience.
Topics: Docetaxel; Humans; Macular Edema; Middle Aged; Paclitaxel; Retrospective Studies; Taxoids | 2022 |
Central Macular Thickness Monitoring after a Taxane-Based Therapy in Visually Asymptomatic Patients.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Docetaxel; Esophageal Neoplasms; Female; Humans; Macula Lutea; Macular Edema; Male; Middle Aged; Ovarian Neoplasms; Taxoids; Tomography, Optical Coherence; Visual Acuity | 2017 |
Bilateral cystoid macular edema following docetaxel chemotherapy in a patient with retinitis pigmentosa: a case report.
Topics: Antineoplastic Agents; Breast Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Electroretinography; Female; Fluorescein Angiography; Fundus Oculi; Humans; Macular Edema; Middle Aged; Retinitis Pigmentosa; Taxoids; Tomography, Optical Coherence; Visual Acuity | 2015 |
Cystic maculopathy with normal capillary permeability secondary to docetaxel.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Capillary Permeability; Docetaxel; Fatal Outcome; Female; Fluorescein Angiography; Humans; Macular Edema; Middle Aged; Paclitaxel; Retinal Vessels; Taxoids; Visual Acuity | 2003 |